MALE | FEMALE | MALE | FEMALE | ||||||
---|---|---|---|---|---|---|---|---|---|
Total sample | 1,111,047 | 49.10% | 1,151,639 | 50.90% | Rheumatoid arthritis and autoimmune and connective tissue diseases | 8,571 | 0.77% | 14,858 | 1.29% |
By age groups | Gout | 19,072 | 1.72% | 3,719 | 0.32% | ||||
0-17 | 175,435 | 15.80% | 164,105 | 14.26% | Chromosomal anomalies or Inherited metabolic disorders | 12,765 | 1.15% | 9,527 | 0.83% |
18-44 | 429,365 | 38.65% | 407,960 | 35.43% | Heart failure | 10,151 | 0.91% | 11,057 | 0.96% |
45-64 | 313,689 | 28.23% | 319,435 | 27.74% | Diverticular disease of intestine | 8,221 | 0.74% | 11,120 | 0.97% |
65-74 | 98,916 | 8.90% | 110,762 | 9.62% | Chronic liver or pancreatic disease | 11,942 | 1.07% | 6,358 | 0.55% |
75+ | 93,642 | 8.43% | 149,377 | 12.98% | Schizophrenia, affective psychosis or bipolar disorder | 8,068 | 0.73% | 7,073 | 0.61% |
Parkinson’s disease | 5,743 | 0.52% | 6,838 | 0.59% | |||||
Prevalence of chronic disease | Viral Hepatitis | 7,083 | 0.64% | 4,510 | 0.39% | ||||
Hypertension | 207,478 | 18.67% | 223,753 | 19.43% | Paralysis or muscular dystrophy | 5,941 | 0.53% | 5,208 | 0.45% |
Anxiety & other neurotic, stress related & somatoform disorders | 80,755 | 7.27% | 161,981 | 14.07% | Irritable bowel syndrome | 3,298 | 0.30% | 6,298 | 0.55% |
Diabetes Mellitus | 70,614 | 6.36% | 60,412 | 5.25% | Alcohol problems | 7,037 | 0.63% | 1,887 | 0.16% |
Degenerative joint disease | 25,897 | 2.33% | 60,878 | 5.29% | Epilepsy (currently treated) | 4,729 | 0.43% | 4,162 | 0.36% |
Treated dyspepsia | 33,624 | 3.03% | 53,088 | 4.61% | Inflammatory bowel disease | 4,381 | 0.39% | 4,314 | 0.37% |
Depression | 19,944 | 1.80% | 59,894 | 5.20% | Peripheral vascular disease | 6,675 | 0.60% | 1,698 | 0.15% |
Hypothyroidism | 11,125 | 1.00% | 67,968 | 5.90% | Treated constipation | 2,484 | 0.22% | 4,729 | 0.41% |
Malignancies | 35,543 | 3.20% | 34,429 | 2.99% | Disorders of the immune system | 2,754 | 0.25% | 3,980 | 0.35% |
Low back pain | 23,777 | 2.14% | 41,352 | 3.59% | Migraine | 1,055 | 0.09% | 5,120 | 0.44% |
Asthma (currently treated) | 30,161 | 2.71% | 33,709 | 2.93% | Developmental disorder | 3,750 | 0.34% | 2,272 | 0.20% |
Glaucoma | 24,827 | 2.23% | 33,274 | 2.89% | Chronic sinusitis | 2,518 | 0.23% | 3,369 | 0.29% |
Osteoporosis | 3,019 | 0.27% | 53,283 | 4.63% | Hematologic chronic disorders | 2,598 | 0.23% | 3,140 | 0.27% |
Atrial fibrillation | 27,818 | 2.50% | 22,860 | 1.98% | Psoriasis or eczema | 2,944 | 0.26% | 2,060 | 0.18% |
Emphysema, chronic bronchitis, COPD | 33,653 | 3.03% | 16,643 | 1.45% | Bronchiectasis | 2,137 | 0.19% | 2,863 | 0.25% |
Peripheral neuropathy, neuritis | 15,561 | 1.40% | 32,028 | 2.78% | Other psycho-active substance misuse | 3,791 | 0.34% | 855 | 0.07% |
Ischemic heart disease | 32,402 | 2.92% | 13,680 | 1.19% | Attention deficit disorder | 2,555 | 0.23% | 844 | 0.07% |
Chronic heart disease, others | 26,611 | 2.40% | 18,637 | 1.62% | HIV, AIDS | 1,796 | 0.16% | 839 | 0.07% |
Cerebro-vascular disease | 22,682 | 2.04% | 22,268 | 1.93% | Transplant status | 1,364 | 0.12% | 764 | 0.07% |
Prostatic hypertrophy | 43,403 | 3.91% | --- | --- | Multiple sclerosis | 628 | 0.06% | 1,308 | 0.11% |
Deafness, hearing loss | 20,264 | 1.82% | 20,518 | 1.78% | Anorexia or bulimia | 109 | 0.01% | 1,377 | 0.12% |
Dementia | 12,308 | 1.11% | 25,141 | 2.18% | |||||
Blindness & low vision | 13,864 | 1.25% | 17,118 | 1.49% | Multimorbidity (2+ conditions) | 235,617 | 21.21% | 298,640 | 25.93% |
Chronic kidney disease | 13,449 | 1.21% | 12,242 | 1.06% |